GHRH and cancer: Growth hormone-releasing hormone antagonist MZ-4-71 at the dose of 0.1 μM decreased the proliferation of T47D, MDA-MB-468, MDA-MB-435s, LNCaP and NCI H838 cancer cell lines by 37, 29, 32, 29, 28% respectively.